Molecular characterization of endocarditis-associated Staphylococcus aureus

Journal of Clinical Microbiology

Volumn 51, Issue 7, 2013, Pages 2131-2138

  Nethercott, Cara ^a   Mabbett, Amanda N ^a   Totsika, Makrina ^a   Peters, Paul ^b   Ortiz, Juan C ^a   Nimmo, Graeme R ^c   Coombs, Geoffrey W ^d   Walker, Mark J ^a   Schembri, Mark A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c Central Queensland Pathology Laboratory   (Australia)

^d ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; GENOMIC DNA; LEUKOCIDIN; STAPHYLOCOCCUS PROTEIN A; VON WILLEBRAND FACTOR; BACTERIAL DNA; VIRULENCE FACTOR;

ADULT; AGED; ALLELE; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL GENE; BACTERIAL SKIN DISEASE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BBP GENE; BIOLOGICAL MONITORING; BLOODSTREAM INFECTION; CLFA GENE; CLFB GENE; DEVICE INFECTION; DNA MICROARRAY; FEMALE; FNBA GENE; FNBB GENE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC VARIABILITY; HSDSX GENE; HUMAN; ISDA GENE; MAJOR CLINICAL STUDY; MALE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MOLECULAR EPIDEMIOLOGY; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; SOFT TISSUE INFECTION; SPA GENE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; VWB GENE; ADOLESCENT; CHILD; CLASSIFICATION; GENETICS; GENOTYPE; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR TYPING; NEWBORN; PRESCHOOL CHILD; VERY ELDERLY; YOUNG ADULT;

STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DNA, BACTERIAL; ENDOCARDITIS, BACTERIAL; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MOLECULAR TYPING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS; YOUNG ADULT;

EID: 84879455364     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00651-13     Document Type: Article

References (39)

1. Fowler VG, Jr, Bayer AS. 2012. Infective endocarditis, p 464-473. In Goldman L, Schafer AI (ed), Goldman's Cecil medicine, 24th ed, vol 1. Elsevier Inc., New York, NY.
2. Que Y-A, Moreillon P. 2011. Infective endocarditis. Nat. Rev. Cardiol. 8:322-336.
3. Sousa C, Botelho C, Rodrigues D, Azeredo J, Oliveira R. 2012. Infective endocarditis in intravenous drug abusers: an update. Eur. J. Clin. Microbiol. Infect. Dis. 31:2905-2910.
4. Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods M-C, Peetermans WE. 2007. Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur. Heart J. 28:196-203.
5. Murdoch DR, Corey G, Hoen B, Miro JM, Fowler VG, Jr, Bayer AS, Karchmer AW. 2009. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis- prospective cohort study. Arch. Intern. Med. 169:463-473.
6. Roig I, Darouiche R, Musher D, Trautner B. 2012. Device-related infective endocarditis, with special consideration of implanted intravascular and cardiac devices in a predominantly male population. Scand. J. Infect. Dis. 44:753-760.
7. Fowler VG, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey R. 2005. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293:3012-3021.
8. Wang A, Athan E, Pappas P, Fowler V, Olaison L, Pare C, Almirante B. 2007. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 297:1354-1361.
9. Fowler VG, Nelson CL, McIntyre LM, Kreiswirth BN, Monk A, Archer GL, Federspiel J, Naidich S, Remortel B, Rude T, Brown P, Reller LB, Corey GR, Gill SR. 2007. Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection. J. Infect. Dis. 196:738-747.
10. Nienaber JJC, Sharma Kuinkel BK, Clarke-Pearson M, Lamlertthon S, Park L, Rude TH, Barriere S, Woods CW, Chu VH, Marín M, Bukovski S, Garcia P, Corey GR, Korman T, Doco-Lecompte T, Murdoch DR, Reller LB, Fowler VG, for the International Collaboration on Endocarditis-Microbiology I. 2011. Methicillin-susceptible Staphylococcus aureus endocarditis isolates are associated with clonal complex 30 genotype and a distinct repertoire of enterotoxins and adhesins. J. Infect. Dis. 204:704-713.
11. Gill SR, McIntyre LM, Nelson CL, Remortel B, Rude T, Reller LB, Fowler VG, Jr. 2011. Potential associations between severity of infection and the presence of virulence-associated genes in clinical strains of Staphylococcus aureus. PLoS One 6:e18673. doi:10.1371/journal.pone.0018673.
12. Tristan A, Rasigade J-P, Ruizendaal E, Laurent F, Bes M, Meugnier H, Lina G, Etienne J, Celard M, Tattevin P, Monecke S, Le Moing V, Vandenesch F, the French AsGoIE. 2012. Rise of CC398 lineage of Staphylococcus aureus among infective endocarditis isolates revealed by two consecutive population-based studies in France. PLoS One 7:e51172. doi: 10.1371/journal.pone.0051172.
13. Feil EJ, Cooper JE, Grundmann H, Robinson DA, Enright MC, Berendt T, Peacock SJ, Smith JM, Murphy M, Spratt BG, Moore CE, Day NPJ. 2003. How clonal is Staphylococcus aureus? J. Bacteriol. 185:3307-3316.
14. Chi C-Y, Wang S-M, Lin C-C, Liu C-C. 2010. Microbiological characteristics of community-associated Staphylococcus aureus causing uncomplicated bacteremia and infective endocarditis. J. Clin. Microbiol. 48:292-294.
15. Hallin M, Friedrich AW, Struelens MJ. 2009. Spa typing for epidemiological surveillance of Staphylococcus aureus. Methods Mol. Biol. 551:189-202.
16. Buck AW, Fowler VG, Yongsunthon R, Liu J, DiBartola AC, Que Y-A, Moreillon P, Lower SK. 2010. Bonds between fibronectin and fibronectin-binding proteins on Staphylococcus aureus and Lactococcus lactis. Langmuir 26:10764-10770.
17. Que Y-A, Haefliger J-A, Piroth L, François P, Widmer E, Entenza JM, Sinha B, Herrmann M, Francioli P, Vaudaux P, Moreillon P. 2005. Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis. J. Exp. Med. 201:1627-1635.
18. Widmer E, Que Y-A, Entenza JM, Moreillon P. 2006. New concepts in the pathophysiology of infective endocarditis. Curr. Infect. Dis. Rep. 8:271-279.
19. Piroth L, Que Y-A, Widmer E, Panchaud A, Piu S, Entenza JM, Moreillon P. 2008. The fibrinogen-and fibronectin-binding domains of Staphylococcus aureus fibronectin-binding protein A synergistically promote endothelial invasion and experimental endocarditis. Infect. Immun. 76:3824-3831.
20. Thakker M, Park J-S, Carey V, Lee JC. 1998. Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model. Infect. Immun. 66:5183-5189.
21. Karakawa WW, Sutton A, Schneerson R, Karpas A, Vann WF. 1988. Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes. Infect. Immun. 56:1090-1095.
22. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, Bashore T, Corey GR. 2000. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin. Infect. Dis. 30:633-638.
23. Enright MC, Day NPJ, Davies CE, Peacock SJ, Spratt BG. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38:1008-1015.
24. Harmsen D, Claus H, Witte W, Rothgänger J, Claus H, Turnwald D, Vogel U. 2003. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J. Clin. Microbiol. 41:5442-5448.
25. Monecke S, Jatzwauk L, Weber S, Slickers P, Ehricht R. 2008. DNA microarray-based genotyping of methicillin-resistant Staphylococcus aureus strains from eastern Saxony. Clin. Microbiol. Infect. 14:534-545.
26. Monecke S, Slickers P, Ehricht R. 2008. Assignment of Staphylococcus aureus isolates to clonal complexes based on microarray analysis and pattern recognition. FEMS Immunol. Med. Microbiol. 53:237-251.
27. Coombs G, Monecke S, Pearson J, Tan H-L, Chew Y-K, Wilson L, Ehricht R, O'Brien F, Christiansen K. 2011. Evolution and diversity of community-associated methicillin-resistant Staphylococcus aureus in a geographical region. BMC Microbiol. 11:215. doi:10.1186/1471-2180-11-215.
28. Wilson GJ, Seo KS, Cartwright RA, Connelley T, Chuang-Smith ON, Merriman JA, Guinane CM, Park JY, Bohach GA, Schlievert PM, Morrison WI, Fitzgerald JR. 2011. A novel core genome-encoded superantigen contributes to lethality of community-associated MRSA necrotizing pneumonia. PLoS Pathog. 7:e1002271. doi:10.1371/journal.ppat.1002271.
29. Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, Kobayashi I, Cui L, Oguchi A, Aoki K, Nagai Y, Lian J, Ito T, Kanamori M, Matsumaru H, Maruyama A, Murakami H, Hosoyama A, Mizutani-Ui Y, Takahashi NK, Sawano T, Inoue R, Kaito C, Sekimizu K, Hirakawa H, Kuhara S, Goto S, Yabuzaki J, Kanehisa M, Yamashita A, Oshima K, Furuya K, Yoshino C, Shiba T, Hattori M, Ogasawara N, Hayashi H, Hiramatsu K. 2001. Whole genome sequencing of methicillin-resistant Staphylococcus aureus. Lancet 357:1225-1240.
30. Arcus VL, Langley R, Proft T, Fraser JD, Baker EN. 2002. The threedimensional structure of a superantigen-like protein, SET3, from a pathogenicity island of the Staphylococcus aureus genome. J. Biol. Chem. 277: 32274-32281.
31. Fraser JD, Proft T. 2008. The bacterial superantigen and superantigenlike proteins. Immunol. Rev. 225:226-243.
32. Colque-Navarro P, Palma M, Söderquist B, Flock J-I, Möllby R. 2000. Antibody responses in patients with staphylococcal septicemia against two Staphylococcus aureus fibrinogen binding proteins: clumping factor and an extracellular fibrinogen binding protein. Clin. Diagn. Lab. Immunol. 7:14-20.
33. Palma M, Shannon O, Quezada HC, Berg A, Flock J-I. 2001. Extracellular fibrinogen-binding protein, Efb, from Staphylococcus aureus blocks platelet aggregation due to its binding to the α-chain. J. Biol. Chem. 276: 31691-31697.
34. Shannon O, Flock J-I. 2004. Extracellular fibrinogen binding protein, Efb, from Staphylococcus aureus binds to platelets and inhibitis platelet aggregation. Thromb Haemost. 91:779-789.
35. Ko Y-P, Liang X, Smith CW, Degen JL, Höök M. 2011. Binding of Efb from Staphylococcus aureus to fibrinogen blocks neutrophil adherence. J. Biol. Chem. 286:9865-9874.
36. Lee LYL, Liang X, Höök M, Brown EL. 2004. Identification and characterization of the C3 binding domain of the Staphylococcus aureus extracellular fibrinogen-binding protein (Efb). J. Biol. Chem. 279:50710-50716.
37. Ricklin D, Ricklin-Lichtsteiner SK, Markiewski MM, Geisbrecht BV, Lambris JD. 2008. Cutting edge: members of the Staphylococcus aureus extracellular fibrinogen-binding protein family inhibit the interaction of C3d with complement receptor 2. J. Immunol. 181:7463-7467.
38. Turner KME, Feil EJ. 2007. The secret life of the multilocus sequence type. Int. J. Antimicrob. Agents 29:129-135.
39. Pozzi C, Waters EM, Rudkin JK, Schaeffer CR, Lohan AJ, Tong P, Loftus BJ, Pier GB, Fey PD, Massey RC, O'Gara JP. 2012. Methicillin resistance alters the biofilm phenotype and attenuates virulence in Staphylococcus aureus device-associated infections. PLoS Pathog. 8:e1002626. doi:10.1371/journal.ppat. 1002626.